“Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma”. Journal of Kidney Cancer, vol. 9, no. 3, Sept. 2022, pp. 29-40, https://doi.org/10.15586/jkcvhl.v9i3.243.